Melatonin vs. tranexamic acid for melasma
Treatments studied
Part of Skin clinical trials.
This study compares two oral treatments—melatonin and tranexamic acid—to see which works better for reducing melasma. Both are pills you take by mouth, and the goal is to find a safe, effective option for people with this skin condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old.
- You have been diagnosed with melasma (dark patches on your face).
- You are not pregnant or breastfeeding, and have no plans to become pregnant during the study.
- You do not have any autoimmune disorders, bleeding problems, or diabetes.
- You have never had a blood clot, stroke, or kidney disease.
- You are not currently using any other treatment for your melasma.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding an oral medicine (tranexamic acid) to a standard triple cream works better for melasma than the cream alone. It may help lighten dark patches on your skin if you have the right type of melasma.
This trial tests a new way to deliver a medicine (tranexamic acid) into melasma patches using ultrasound waves. It aims to see if the ultrasound helps the medicine work better to lighten the dark spots.
This trial tests a microneedling technique combined with three topical medications (metformin, tranexamic acid, and a modified Kligman's formula) to treat melasma, a common skin condition causing dark patches. The goal is to see if this approach safely and effectively reduces melasma in eligible women.
This trial compares a new cosmetic serum to a standard treatment (4% hydroquinone) for facial melasma over 84 days. It may help if you have mild to moderate melasma and are looking for a gentler alternative.
This study compares a metformin cream to a standard treatment (Kligman's regimen) for reducing melasma, a common skin condition causing dark patches on the face. It aims to find which treatment is more effective for women with this condition.
This trial tests two injectable treatments for melasma (dark patches on the face): platelet-rich fibrin, which uses your own blood cells to promote healing, and tranexamic acid, a medication that may reduce pigmentation. The study will compare which works better for women with mild to moderate melasma.
Hear when a new Melasma (Facial Melasma) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.